DMAC - DiaMedica Therapeutics Inc.

QQQ $ 463.74 $ 0.15 (0.03 %)

DIA $ 400.12 $ 2.30 (0.58 %)

SPY $ 543.85 $ 1.71 (0.32 %)

TLT $ 97.88 $ 0.61 (0.63 %)

GLD $ 226.19 $ -1.86 (-0.82 %)

Previous Close

$ 3.48

Open

Bid

$ 3.47 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.94 - $ 3.81

Volume

10,604

Average Volume

Market Cap

148.76M

Beta (5Y Monthly)

$ 0.98

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	03-19-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-28-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	03-14-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-11-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	03-10-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	08-11-2020	06-30-2020	10-Q
18	05-13-2020	03-31-2020	10-Q
19	03-23-2020	12-31-2019	10-K
20	11-13-2019	09-30-2019	10-Q
21	08-13-2019	06-30-2019	10-Q
22	05-13-2019	03-31-2019	10-Q
23	03-19-2019	12-31-2018	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

DiaMedica Reiterates Its Guidance That Ful...
08/07/2024 20:58:35

DiaMedica Therapeutics Q2 2024 GAAP EPS $(...
08/07/2024 20:57:59

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate o...

DiaMedica Therapeutics Releases Preeclamps...
07/11/2024 12:14:33

Company to Host Preeclampsia Key Opinion Leader Event July 29, 2024 at 10 AM Eastern / 9 AM CentralWhite Paper: The Potential o...

DiaMedica Therapeutics Files For Resale Of...
07/10/2024 20:26:17

- SEC Filing

DiaMedica Therapeutics Announces $11.8M Pr...
06/26/2024 12:17:40

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments fo...

DiaMedica Therapeutics Announces Expansion...
06/26/2024 12:01:10

Preeclampsia Program to be Initiated with a Phase 2 Investigator-sponsored Trial Beginning in Q4 2024Key Proof-of-Concept Resu...

DiaMedica Therapeutics Q1 2024 GAAP EPS $(...
05/08/2024 22:39:50

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate o...

Craig-Hallum Assumes DiaMedica Therapeutic...
04/24/2024 17:33:22

Craig-Hallum analyst Alexander Nowak assumes DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy rating and announces Price Targ...

DiaMedica Therapeutics Doses First Patient...
04/17/2024 20:08:51

Craig-Hallum Maintains Buy on DiaMedica Th...
03/21/2024 18:31:19

Craig-Hallum analyst Alexander Nowak maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and lowers the price target f...

Oppenheimer Reiterates Outperform on DiaMe...
03/21/2024 12:43:47

Oppenheimer analyst Francois Brisebois reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Outperform and lowers the pric...

Recap: DiaMedica Therapeutics Q4 Earnings
03/19/2024 21:25:11

DiaMedica Therapeutics FY23 EPS $(0.60) Vs...
03/19/2024 20:31:05

Financial ResultsResearch and development (R&D) expenses increased to $13.1 million for the year ended December 31, 2023, u...

DiaMedica Therapeutics Q3 EPS $(0.12) Beat...
11/13/2023 21:57:37

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate o...

Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

Earnings Outlook For DiaMedica Therapeutics
11/10/2023 17:02:09

DiaMedica Therapeutics Q2 EPS $(0.16) Beat...
08/14/2023 20:48:05

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate o...

Earnings Scheduled For August 14, 2023
08/14/2023 10:45:55

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per ...

Benzinga's Top Ratings Upgrades, Downgrade...
06/22/2023 15:02:26

Oppenheimer Upgrades DiaMedica Therapeutic...
06/22/2023 11:16:31

Oppenheimer analyst Francois Brisebois upgrades DiaMedica Therapeutics (NASDAQ:DMAC) from Perform to Outperform and announce...